SASHA MILKS: Open Payments
NPI 1861025918 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,929 in 123 payments from 20 companies in 2025. Trend: 2023 $1,936 · 2024 $2,069 · 2025 $1,929
Food & beverage: $1,929
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $751 |
| Novo Nordisk Inc | 14 | $221 |
| Otsuka America Pharmaceutical, Inc. | 10 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $126 |
| Axsome Therapeutics, Inc. | 5 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| Lilly USA, LLC | 4 | $73 |
| PFIZER INC. | 3 | $62 |
| Exact Sciences Corporation | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
Products named: BOTOX, VRAYLAR, REXULTI, CAPLYTA, Ozempic, XIFAXAN, Rybelsus, Auvelity.
Industry payments across GA — which companies pay providers there.
